- Home
- HOUR vs RLMD Comparison
HOUR vs RLMD Comparison
Compare HOUR & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- RLMD
- Stock Information
- Founded
- HOUR 2015
- RLMD 2004
- Country
- HOUR United States
- RLMD United States
- Employees
- HOUR N/A
- RLMD 17
- Industry
- HOUR Catalog/Specialty Distribution
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- HOUR Consumer Discretionary
- RLMD Health Care
- Exchange
- HOUR Nasdaq
- RLMD Nasdaq
- Market Cap
- HOUR 63.3M
- RLMD 52.8M
- IPO Year
- HOUR 2022
- RLMD N/A
- Fundamental
- Price
- HOUR $3.59
- RLMD $1.59
- Analyst Decision
- HOUR
- RLMD Buy
- Analyst Count
- HOUR 0
- RLMD 3
- Target Price
- HOUR N/A
- RLMD $5.00
- AVG Volume (30 Days)
- HOUR 14.5M
- RLMD 1.6M
- Earning Date
- HOUR 11-11-2025
- RLMD 11-06-2025
- Dividend Yield
- HOUR N/A
- RLMD N/A
- EPS Growth
- HOUR N/A
- RLMD N/A
- EPS
- HOUR 0.02
- RLMD N/A
- Revenue
- HOUR $138,441,228.00
- RLMD N/A
- Revenue This Year
- HOUR N/A
- RLMD N/A
- Revenue Next Year
- HOUR N/A
- RLMD N/A
- P/E Ratio
- HOUR $163.02
- RLMD N/A
- Revenue Growth
- HOUR N/A
- RLMD N/A
- 52 Week Low
- HOUR $1.10
- RLMD $0.24
- 52 Week High
- HOUR $6.90
- RLMD $3.98
- Technical
- Relative Strength Index (RSI)
- HOUR 60.65
- RLMD 74.57
- Support Level
- HOUR $3.00
- RLMD $1.44
- Resistance Level
- HOUR $6.84
- RLMD $1.72
- Average True Range (ATR)
- HOUR 0.75
- RLMD 0.24
- MACD
- HOUR 0.20
- RLMD 0.05
- Stochastic Oscillator
- HOUR 41.96
- RLMD 86.90
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.